This company listing is no longer active
Delta 9 Cannabis Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Delta 9 Cannabis.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 65.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
It's Unlikely That Shareholders Will Increase Delta 9 Cannabis Inc.'s (TSE:DN) Compensation By Much This Year
Jun 21
It's Down 29% But Delta 9 Cannabis Inc. (TSE:DN) Could Be Riskier Than It Looks
May 10Delta 9 Cannabis Inc.'s (TSE:DN) Shares Leap 122% Yet They're Still Not Telling The Full Story
Mar 26Market Might Still Lack Some Conviction On Delta 9 Cannabis Inc. (TSE:DN) Even After 122% Share Price Boost
Mar 26Is Delta 9 Cannabis (TSE:DN) Using Too Much Debt?
Sep 09Delta 9 Cannabis Inc. (TSE:DN) Not Doing Enough For Some Investors As Its Shares Slump 27%
Jul 28Does Delta 9 Cannabis (TSE:DN) Have A Healthy Balance Sheet?
Aug 19Is Delta 9 Cannabis (TSE:DN) A Risky Investment?
Jan 11Delta 9 Cannabis (TSE:DN) Is Making Moderate Use Of Debt
Sep 28Delta 9 Cannabis (TSE:DN) Is Carrying A Fair Bit Of Debt
Apr 08John Arbuthnot Is The Co-Founder of Delta 9 Cannabis Inc. (TSE:DN) And They Just Picked Up 1.0% More Shares
Dec 24
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Delta 9 Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2024 | 71 | -20 | 4 | 4 | N/A |
| 12/31/2023 | 71 | -18 | 4 | 4 | N/A |
| 9/30/2023 | 71 | -22 | 4 | 5 | N/A |
| 6/30/2023 | 68 | -24 | 3 | 4 | N/A |
| 3/31/2023 | 68 | -26 | -3 | -1 | N/A |
| 12/31/2022 | 63 | -27 | -6 | -4 | N/A |
| 9/30/2022 | 63 | -21 | -7 | -5 | N/A |
| 6/30/2022 | 62 | -14 | -8 | -6 | N/A |
| 3/31/2022 | 62 | -11 | -4 | -1 | N/A |
| 12/31/2021 | 62 | -11 | -3 | -1 | N/A |
| 9/30/2021 | 59 | -8 | -6 | -2 | N/A |
| 6/30/2021 | 57 | -12 | -6 | -3 | N/A |
| 3/31/2021 | 54 | -13 | -7 | -2 | N/A |
| 12/31/2020 | 52 | -6 | -4 | 2 | N/A |
| 9/30/2020 | 48 | -8 | -6 | 0 | N/A |
| 6/30/2020 | 42 | -4 | -10 | 1 | N/A |
| 3/31/2020 | 38 | -3 | -16 | -3 | N/A |
| 12/31/2019 | 32 | 11 | -26 | -12 | N/A |
| 9/30/2019 | 26 | 12 | -34 | -10 | N/A |
| 6/30/2019 | 21 | 11 | -35 | -14 | N/A |
| 3/31/2019 | 13 | 10 | -35 | -15 | N/A |
| 12/31/2018 | 8 | -8 | -26 | -9 | N/A |
| 9/30/2018 | 3 | -12 | -16 | -11 | N/A |
| 6/30/2018 | 2 | -11 | -10 | -7 | N/A |
| 3/31/2018 | 1 | -9 | -7 | -5 | N/A |
| 12/31/2017 | 1 | -8 | N/A | -5 | N/A |
| 9/30/2017 | 1 | -2 | N/A | -3 | N/A |
| 6/30/2017 | 1 | -2 | N/A | -2 | N/A |
| 3/31/2017 | 1 | -1 | N/A | -1 | N/A |
| 12/31/2016 | 0 | -1 | N/A | -1 | N/A |
| 12/31/2015 | 1 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if DN's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if DN's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if DN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if DN's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if DN's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DN's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/25 12:57 |
| End of Day Share Price | 2024/07/15 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Delta 9 Cannabis Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kimberly Thompson-Hedlin | Canaccord Genuity |
| Siddharth Rajeev | Fundamental Research Corp. |
| Venkata Velagapudi | Research Capital Corporation |